Cargando…
Ultralow-dose Dexamethasone to Preserve Endogenous Cortisol Stress Response in Nonclassical Congenital Adrenal Hyperplasia: A New Promising Treatment
INTRODUCTION: Nonclassical congenital adrenal hyperplasia (CAH) is characterized by sufficient cortisol and aldosterone production at the cost of androgen overproduction. Hydrocortisone or dexamethasone in supraphysiological doses are current treatment; however, their downside is suppression of endo...
Autores principales: | van der Kaay, Danielle, van den Akker, Erica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166204/ https://www.ncbi.nlm.nih.gov/pubmed/25237318 http://dx.doi.org/10.5812/ijem.14657 |
Ejemplares similares
-
Nonclassic Congenital Adrenal Hyperplasia
por: Witchel, Selma Feldman, et al.
Publicado: (2010) -
Nonclassical Congenital Adrenal Hyperplasia and Pregnancy
por: Cuhaci, Neslihan, et al.
Publicado: (2015) -
Nonclassic congenital adrenal hyperplasia misdiagnosed as Turner syndrome
por: Mishra, Vineet V., et al.
Publicado: (2015) -
Bilateral testicular adrenal rest tumors in a patient with nonclassical congenital adrenal hyperplasia
por: Roberts, Erica C, et al.
Publicado: (2021) -
Revisiting the prevalence of nonclassic congenital adrenal hyperplasia in US Ashkenazi Jews and Caucasians
por: Hannah-Shmouni, Fady, et al.
Publicado: (2017)